Related Experiment Video
Updated: Oct 25, 2025

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Biomarkers in Cardiorenal Syndrome
Giovanni Goffredo1,2, Roberta Barone1,2, Vito Di Terlizzi1,2
1Department of Medical and Surgical Sciences, University of Foggia, Viale Luigi Pinto 1, 71122 Foggia, Italy.
Insights
Cardiorenal syndrome involves complex heart and kidney interactions. This review explores new biomarkers to assess kidney function and predict worsening in cardiovascular patients.
Area of Science:
- Cardiology
- Nephrology
- Biomarker Research
Background:
- Cardiorenal syndrome (CRS) highlights the intricate relationship between heart and kidney diseases.
- Accurate assessment of renal function is crucial in patients with cardiovascular conditions.
- Identifying individuals at risk for acute or chronic kidney function decline is a clinical priority.
Purpose of the Study:
- To review the clinical utility of novel biomarkers in managing cardiorenal syndrome.
- To provide an overview of recent advancements in CRS biomarker research.
- To identify biomarkers that can improve risk stratification in CRS patients.
Main Methods:
- Literature review of recent studies on cardiorenal syndrome biomarkers.
- Analysis of biomarker performance in assessing renal function.
- Evaluation of biomarkers for predicting renal outcomes in cardiovascular disease.
Main Results:
- Emerging biomarkers show promise in evaluating renal status in CRS.
- Certain biomarkers may help identify patients at higher risk of renal deterioration.
- The clinical application of these biomarkers requires further validation.
Conclusions:
- New biomarkers offer potential for improved management of cardiorenal syndrome.
- Further research is needed to establish the definitive role of these biomarkers in clinical practice.
- Biomarker-guided strategies could enhance patient care in CRS.
Abstract:
Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases. Over the last years, in patients with cardiovascular diseases, several biomarkers have been studied in order to better assess renal function as well as to identify patients prone to experiencing chronic or acute worsening of renal function. The aim of this review is to focus on the possible clinical usefulness of the most recent biomarkers in the setting of cardiorenal syndrome.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Serum Studies: Renal Function Tests
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

